Briet, M., Boutouyrie, P., Laurent, S
GLP-1 medications are a class of drugs that help regulate appetite, blood sugar, and satiety by mimicking naturally occurring gut hormones involved in metabolism
Research interest centers on the compound's proposed capacity to potentiate HGF activity at the MET receptor, with particular attention to downstream effects on synaptic density and cognitive function-related signalling in neurological research models
The association between alcohol intake and fecundability during menstrual cycle phases
Patients who report the symptom most often experience it during dose escalation or the first month of treatment, when metabolic adjustment is greatest
Growing evidence shows that insulin resistance (IR) in the brain can challenge neural function, which is why AD is often termed Type 3 diabetes. Current drugs like TRZ, which activates both glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP) receptors, are under investigation for their neuroprotective potential